The development of an organism largely depends on the orchestration between cellular growth and the timing of developmental cell cycles, which is fine tuned by several genes. The transcript stability and abundance of these genes during development and throughout adulthood regulates animal form and function while mutation in them causes the cells to lose control over the timely progression of developmental cell cycles and may trigger tumorigenesis. mRNA decapping is a key step of mRNA degradation involving the removal of the 5'm7G cap of mRNAs. In Drosophila melanogaster, the mRNA decapping enzyme 2-DCP2, performs this step in association with other proteins. DCP2 has been studied extensively in various model organisms in the light of maintenance of transcript abundance and stability. In Drosophila melanogaster, loss-of-function alleles of DCP2, viz., DCP2BG01766 and DCP2e00034 cause absolute embryonic lethality in homozygotes, whereas another allele, DCP2l(3)tb causes larval brain tumors and absolute pupal lethality in the homozygotes. DCP2BG01766 and DCP2l(3)tb show defects in cuticular denticles and elevated expression of activated JNK in the cells of the lateral epidermis. Parallely, the DCP2BG01766 mutant embryos show accumulation of Rab11, a vesicular trafficking protein in the lateral epidermis as well as elevated expression of activated JNK in the cells of the neuro-ectoderm. The tumorous allele, DCP2l(3)tb exhibits hyperplastic nature, with increased number and size of cells without loss of epithelial polarity along with impaired fasciculation of axons, implying DCP2 to be an essential candidate for development of the nervous system in Drosophila. Taken together, our results shed light on hitherto undescribed roles of DCP2 during Drosophila development, besides its cognate function. Inherited muscular dystrophies are developmental disorders of muscle cells and tissues; understanding how muscle development is disrupted by disease mutations may contribute to developing treatments. An early stage of muscle development involves the differentiation of myoblasts by cell fusion into myotubes, where multiple nuclei are linearly and evenly spaced in a syncytium, in part by microtubule motor activity. During this process, multiple subcellular components are dramatically reorganized. In particular, the microtubule organizing centre (MTOC) relocalizes from the compact volume of the myoblast centrosome to become uniformly distributed on the myotube nuclear envelope surface. The function and molecular mechanism of MTOC relocation is unclear but coincides with increased expression of the nuclear envelope (NE) protein Nesprin-1. Upon siRNA depletion or CRISPR disruption of Nesprin-1 in C2C12 myotubes, and in congenital muscular dystrophy patient myotubes mutant for Nesprin-1, we found that microtubule nucleation from the NE is abrogated, representing loss of NE MTOC activity. Using proximity-dependent biotin identification (BioID) with Nesprin-1 as bait, we identified the centrosome proteins Pcnt, Akap450, and Pcm1 as potential Nesprin-1 interactors. Pcnt, Akap450 and Pcm1 all localized to the myotube NE in a Nesprin-1-dependent fashion. Intriguingly, Pcnt and Akap450 are scaffolds for the microtubule-nucleating gamma-tubulin complexes. However, only loss of Akap450, but not Pcnt or Pcm1, disrupted MT nucleation from the NE. Thus NE MTOC activity is mediated by Nesprin-1 recruitment of Akap450, which in turn recruits MT nucleation activity to the NE. We found that Nesprin-1 is required for proper nuclear positioning in C2C12 and human myotubes. Using computational modeling, we determined that Nesprin-1 recruitment of both MTOC and kinesin motor activity to the NE is required for this process. Thus disruption of microtubule nucleation and motor activity at the nuclear envelope may contribute to congenital muscular dystrophy by blocking appropriate nuclear migration in myotubes. Nuclear pore complexes (NPCs) are large protein complexes embedded in the nuclear envelope as a selective gate for nucleocytoplasmic trafficking of macromolecules. Additionally, NPCs also function as scaffolds that spatially confine certain biological Abstracts S63
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The development of an organism largely depends on the orchestration between cellular growth and the timing of developmental cell cycles, which is fine tuned by several genes. The transcript stability and abundance of these genes during development and throughout adulthood regulates animal form and function while mutation in them causes the cells to lose control over the timely progression of developmental cell cycles and may trigger tumorigenesis. mRNA decapping is a key step of mRNA degradation involving the removal of the 5'm7G cap of mRNAs. In Drosophila melanogaster, the mRNA decapping enzyme 2-DCP2, performs this step in association with other proteins. DCP2 has been studied extensively in various model organisms in the light of maintenance of transcript abundance and stability. In Drosophila melanogaster, loss-of-function alleles of DCP2, viz., DCP2BG01766 and DCP2e00034 cause absolute embryonic lethality in homozygotes, whereas another allele, DCP2l(3)tb causes larval brain tumors and absolute pupal lethality in the homozygotes. DCP2BG01766 and DCP2l(3)tb show defects in cuticular denticles and elevated expression of activated JNK in the cells of the lateral epidermis. Parallely, the DCP2BG01766 mutant embryos show accumulation of Rab11, a vesicular trafficking protein in the lateral epidermis as well as elevated expression of activated JNK in the cells of the neuro-ectoderm. The tumorous allele, DCP2l(3)tb exhibits hyperplastic nature, with increased number and size of cells without loss of epithelial polarity along with impaired fasciculation of axons, implying DCP2 to be an essential candidate for development of the nervous system in Drosophila. Taken together, our results shed light on hitherto undescribed roles of DCP2 during Drosophila development, besides its cognate function. Inherited muscular dystrophies are developmental disorders of muscle cells and tissues; understanding how muscle development is disrupted by disease mutations may contribute to developing treatments. An early stage of muscle development involves the differentiation of myoblasts by cell fusion into myotubes, where multiple nuclei are linearly and evenly spaced in a syncytium, in part by microtubule motor activity. During this process, multiple subcellular components are dramatically reorganized. In particular, the microtubule organizing centre (MTOC) relocalizes from the compact volume of the myoblast centrosome to become uniformly distributed on the myotube nuclear envelope surface. The function and molecular mechanism of MTOC relocation is unclear but coincides with increased expression of the nuclear envelope (NE) protein Nesprin-1. Upon siRNA depletion or CRISPR disruption of Nesprin-1 in C2C12 myotubes, and in congenital muscular dystrophy patient myotubes mutant for Nesprin-1, we found that microtubule nucleation from the NE is abrogated, representing loss of NE MTOC activity. Using proximity-dependent biotin identification (BioID) with Nesprin-1 as bait, we identified the centrosome proteins Pcnt, Akap450, and Pcm1 as potential Nesprin-1 interactors. Pcnt, Akap450 and Pcm1 all localized to the myotube NE in a Nesprin-1-dependent fashion. Intriguingly, Pcnt and Akap450 are scaffolds for the microtubule-nucleating gamma-tubulin complexes. However, only loss of Akap450, but not Pcnt or Pcm1, disrupted MT nucleation from the NE. Thus NE MTOC activity is mediated by Nesprin-1 recruitment of Akap450, which in turn recruits MT nucleation activity to the NE. We found that Nesprin-1 is required for proper nuclear positioning in C2C12 and human myotubes. Using computational modeling, we determined that Nesprin-1 recruitment of both MTOC and kinesin motor activity to the NE is required for this process. Thus disruption of microtubule nucleation and motor activity at the nuclear envelope may contribute to congenital muscular dystrophy by blocking appropriate nuclear migration in myotubes. A hallmark of living cells is the ability to generate copies of them but also to give rise to differentiated cell types. Every cell has to make a binary choice between "symmetric or asymmetric" cell divisions. The facultative switch between these two division patterns also allows for tissue homeostasis in many stem cells. However, much is still unknown about the mechanism behind division making in these cells. To assess such mechanisms underlying the regulatory switch of division patterns, we have developed a system with C. elegans two-celled zygotes: one of the blastomeres undergoes symmetric division, while other commits to asymmetric division. By artificially manipulated spatial pattern of PAR polarity and segregation of fate determinants, we found that tipping the balance of antagonizing PAR proteins, PAR-2 and PAR-6, is sufficient to reprogram cell division patterns, resulting in all combinations of asymmetric and/or symmetric divisions at two-celled zygotes. The choice of division patterns does not rely on segregation of fate determinants, cellular size asymmetry, and cell cycle asynchrony. Our findings support the model where balance between antagonizing PAR levels within a cell is the critical determinant for its choice in division patterns. In a recent systematic screen in zebrafish embryos for novel ciliary genes upregulated by Foxj1, the master trancriptonal regulator of ciliogenesis, we have identified two genes named pkh1l1α and pkhd1l1β. The encoded proteins, which are predicted to be large single pass transmembrane proteins of about 4000 amino acids, are structurally similar to human PKHD1, mutation of which causes autosomal recessive polycystic kidney disease. In humans, PKDH1L1 has been shown to be upregulated in activated T CD4 + and T CD8 + cytotoxic cells, and is a marker for endometrial carcinoma. In the mouse, Pkhd1l1 mRNA is expressed in the female and the male reproductive system. We have shown, using qRT-PCR experiments, that both zebrafish genes are upregulated by Foxj1. In addition, Xenopus embryos deficient in Pkhd1l1 have epidermal multiciliated cells with shortened and fewer cilia. Using the CRISPR/Cas9 technology we have generated putative loss-of-function alleles (insertion and deletion, respectively) at the pkh1l1α and pkhd1l1β loci. In addition, we have generated transgenic zebrafish carrying GFP tagged Pkhd1l1 proteins that will allow us to visualize their distribution at the subcellular level. Finally, we are also analysing mice mutant for the Pkhd1l1 gene. Results of all of these experiments will be presented and discussed. What will be shown here is that axial extension requires that epiblast cells undergo a type of epithelial to mesenchymal transition (EMT) different to the classical one involved in mesoderm formation. The vertebrate body is laid down progressively in an anterior to posterior sequence by dedicated axial progenitors, first located in the epiblast and later in the tail bud. Both types of axial progenitors share their ability to produce neural and mesodermal structures, but they do it following different routes. Those in the epiblast generate the spinal cord by extending an open neural plate that then closes dorsally to form a tube (the so-called primary neurulation). Mesodermal structures are generated from these progenitors by gastrulation, a process involving an EMT. Tail bud axial progenitors form the neural tube following the so-called secondary neurulation, (i.e. as a solid rod that then cavitates to generate the ependymal canal) and mesoderm formation from these progenitors does not require an EMT as they are already mesenchymal. Tail bud axial progenitors are thought to derive from their epiblast counterparts but the mechanisms involved in this process and their regulation are totally unknown. We will show that tail bud progenitors indeed derive from epiblast progenitors through a process involving activation of a functionally different EMT in the epiblast axial progenitors that, instead of promoting mesodermal fates, keep their activity as progenitors but changing their functional properties so that they now extend the body axis by generating secondary body structures. We will show that Snai1 is the key regulator of this process as it is blocked in the absence of this gene and premature Snai1 activation generates ectopic tail bud-like axial progenitors able to produce an extra neural tube by secondary neurulation. The details of this process and its regulation will be discussed. 
